ROBERT DARWIN has a broad international practice focused on private equity and M&A. He executes the most strategic and critical private transactions for global corporates, funds, and other private investors. Robert advises clients across a wide range of industries including industrials, technology, consumer goods, and leisure. He has been described as “brilliant and incisive” (The Legal 500 UK 2021), a “highly-rated private equity partner” (Legal Business 2019), and “a very adept negotiator who knows when to be tough and when to be pragmatic,” with “outstanding technical skills” (The Legal 500 UK 2021).
Robert is particularly known for his work with global life sciences and healthcare corporations and investors and has led deals of all types in these industries, including strategic collaborations, acquisitions, private equity buyouts, licensing, and investment deals.
The Legal 500 UK 2022 ranks Robert as a “leading individual” for Life Sciences and Healthcare and recognizes him for M&A: Upper Mid-Market and Premium Deals. A client describes him as “exceptional,” and “professional, knowledgeable and service orientated.” Another observes that “his knowledge of the [life sciences] industry, the key players, the norms and the trends allows him to provide advice that is pragmatic and grounded, and engage in creative problem solving” (The Legal 500 UK 2022).